☰

Nir London - Publications

Affiliations: 
2015- Weizmann Institute of Science, Rehovot, Israel 
Area:
Chemical biology, drug discovery and design
Website:
https://www.weizmann.ac.il/Organic_Chemistry/London/
Tree Info Similar researchers PubMed Report error

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Algranati D, Oren R, Dassa B, Fellus-Alyagor L, Plotnikov A, Barr H, Harmelin A, London N, Ron G, Furth N, Shema E. Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas. Elife. 13. PMID 39093942 DOI: 10.7554/eLife.96257  0.12
2024 McCorkindale W, Filep M, London N, Lee AA, King-Smith E. Deconvoluting low yield from weak potency in direct-to-biology workflows with machine learning. Rsc Medicinal Chemistry. 15: 1015-1021. PMID 38516605 DOI: 10.1039/d3md00719g  0.12
2023 Gabizon R, Tivon B, Reddi RN, van den Oetelaar MCM, Amartely H, Cossar PJ, Ottmann C, London N. A simple method for developing lysine targeted covalent protein reagents. Nature Communications. 14: 7933. PMID 38040731 DOI: 10.1038/s41467-023-42632-5  0.774
2023 Boby ML, Fearon D, Ferla M, Filep M, Koekemoer L, Robinson MC, Chodera JD, Lee AA, London N, von Delft A, von Delft F, Achdout H, Aimon A, Alonzi DS, Arbon R, et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science (New York, N.Y.). 382: eabo7201. PMID 37943932 DOI: 10.1126/science.abo7201  0.739
2023 Saar KL, McCorkindale W, Fearon D, Boby M, Barr H, Ben-Shmuel A, London N, von Delft F, Chodera JD, Lee AA. Turning high-throughput structural biology into predictive inhibitor design. Proceedings of the National Academy of Sciences of the United States of America. 120: e2214168120. PMID 36877844 DOI: 10.1073/pnas.2214168120  0.359
2023 Vanhoutte R, Barniol-Xicota M, Chiu W, Vangeel L, Jochmans D, De Jonghe S, Zidane H, Barr HM, London N, Neyts J, Verhelst SHL. Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells. Chemical Science. 14: 1666-1672. PMID 36819852 DOI: 10.1039/d2sc04147b  0.12
2023 Reddi RN, Rogel A, Gabizon R, Rawale DG, Harish B, Marom S, Tivon B, Arbel YS, Gurwicz N, Oren R, David K, Liu J, Duberstein S, Itkin M, Malitsky S, ... ... London N, et al. Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry. Journal of the American Chemical Society. PMID 36738297 DOI: 10.1021/jacs.2c08853  0.753
2022 Bejan DS, Sundalam S, Jin H, Morgan RK, Kirby IT, Siordia IR, Tivon B, London N, Cohen MS. Structure-guided design and characterization of a clickable, covalent PARP16 inhibitor. Chemical Science. 13: 13898-13906. PMID 36544740 DOI: 10.1039/d2sc04820e  0.28
2022 Hassan A, Pollak YE, Kilav-Levin R, Silver J, London N, Nechama M, Ben-Dov IZ, Naveh-Many T. Kidney Failure Alters Parathyroid Pin1 Phosphorylation and Parathyroid Hormone mRNA-Binding Proteins Leading to Secondary Hyperparathyroidism. Journal of the American Society of Nephrology : Jasn. PMID 35961788 DOI: 10.1681/ASN.2022020197  0.135
2022 Gehrtz P, Marom S, Bührmann M, Hardick J, Kleinbölting S, Shraga A, Dubiella C, Gabizon R, Wiese JN, Müller MP, Cohen G, Babaev I, Shurrush K, Avram L, Resnick E, ... ... London N, et al. Optimization of Covalent MKK7 Inhibitors Crude Nanomole-Scale Libraries. Journal of Medicinal Chemistry. PMID 35912476 DOI: 10.1021/acs.jmedchem.1c02206  0.226
2022 Jose A, Guest D, LeGay R, Tizzard GJ, Coles SJ, Derveni M, Wright E, Marrison L, Lee AA, Morris A, Robinson M, von Delft F, Fearon D, Koekemoer L, Matviuk T, ... ... London N, et al. Expanding the Repertoire of Low-Molecular-Weight Pentafluorosulfanyl-Substituted Scaffolds. Chemmedchem. e202100641. PMID 35191598 DOI: 10.1002/cmdc.202100641  0.209
2021 Reddi RN, Rogel A, Resnick E, Gabizon R, Prasad PK, Gurwicz N, Barr H, Shulman Z, London N. Site-Specific Labeling of Endogenous Proteins Using CoLDR Chemistry. Journal of the American Chemical Society. 143: 20095-20108. PMID 34817989 DOI: 10.1021/jacs.1c06167  0.757
2021 Tivon B, Gabizon R, Somsen BA, Cossar PJ, Ottmann C, London N. Covalent flexible peptide docking in Rosetta. Chemical Science. 12: 10836-10847. PMID 34476063 DOI: 10.1039/d1sc02322e  0.12
2021 Koikawa K, Kibe S, Suizu F, Sekino N, Kim N, Manz TD, Pinch BJ, Akshinthala D, Verma A, Gaglia G, Nezu Y, Ke S, Qiu C, Ohuchida K, Oda Y, ... ... London N, et al. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy. Cell. PMID 34388391 DOI: 10.1016/j.cell.2021.07.020  0.072
2021 Klompus S, Leviatan S, Vogl T, Mazor RD, Kalka IN, Stoler-Barak L, Nathan N, Peres A, Moss L, Godneva A, Kagan Ben Tikva S, Shinar E, Dvashi HC, Gabizon R, London N, et al. Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers. Science Immunology. 6. PMID 34326184 DOI: 10.1126/sciimmunol.abe9950  0.153
2021 Zaidman D, Gehrtz P, Filep M, Fearon D, Gabizon R, Douangamath A, Prilusky J, Duberstein S, Cohen G, Owen CD, Resnick E, Strain-Damerell C, Lukacik P, Barr H, ... ... London N, et al. An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M inhibitor. Cell Chemical Biology. PMID 34174194 DOI: 10.1016/j.chembiol.2021.05.018  0.12
2021 von Delft F, Calmiano M, Chodera J, Griffen E, Lee A, London N, Matviuk T, Perry B, Robinson M, von Delft A. A white-knuckle ride of open COVID drug discovery. Nature. 594: 330-332. PMID 34127864 DOI: 10.1038/d41586-021-01571-1  0.091
2021 Rogawski R, Rogel A, Bloch I, Gal M, Horovitz A, London N, Sharon M. Intracellular protein-drug interactions probed by direct mass spectrometry of cell lysates. Angewandte Chemie (International Ed. in English). PMID 34101963 DOI: 10.1002/anie.202104947  0.288
2021 Shorer Arbel Y, Katz BZ, Gabizon R, Shraga A, Bronstein Y, Kamdjou T, Globerson Levin A, Perry C, Avivi I, London N, Herishanu Y. Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells. Frontiers in Oncology. 11: 646971. PMID 34055615 DOI: 10.3389/fonc.2021.646971  0.12
2021 Morris A, McCorkindale W, Consortium TCM, Drayman N, Chodera JD, Tay S, London N, Lee AA. Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed design model. Chemical Communications (Cambridge, England). PMID 34008627 DOI: 10.1039/d1cc00050k  0.243
2021 Dubiella C, Pinch BJ, Koikawa K, Zaidman D, Poon E, Manz TD, Nabet B, He S, Resnick E, Rogel A, Langer EM, Daniel CJ, Seo HS, Chen Y, Adelmant G, ... ... London N, et al. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo. Nature Chemical Biology. PMID 33972797 DOI: 10.1038/s41589-021-00786-7  0.231
2021 Gehrtz P, London N. Electrophilic Natural Products as Drug Discovery Tools. Trends in Pharmacological Sciences. 42: 434-447. PMID 33902949 DOI: 10.1016/j.tips.2021.03.008  0.12
2021 Reddi RN, Resnick E, Rogel A, Rao BV, Gabizon R, Goldenberg K, Gurwicz N, Zaidman D, Plotnikov A, Barr H, Shulman Z, London N. Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry. Journal of the American Chemical Society. PMID 33761747 DOI: 10.1021/jacs.0c10644  0.744
2021 Gabizon R, London N. The rise of covalent proteolysis targeting chimeras. Current Opinion in Chemical Biology. 62: 24-33. PMID 33549806 DOI: 10.1016/j.cbpa.2020.12.003  0.12
2020 Faust O, Abayev-Avraham M, Wentink AS, Maurer M, Nillegoda NB, London N, Bukau B, Rosenzweig R. HSP40 proteins use class-specific regulation to drive HSP70 functional diversity. Nature. PMID 33177718 DOI: 10.1038/s41586-020-2906-4  0.226
2020 Douangamath A, Fearon D, Gehrtz P, Krojer T, Lukacik P, Owen CD, Resnick E, Strain-Damerell C, Aimon A, Ábrányi-Balogh P, Brandão-Neto J, Carbery A, Davison G, Dias A, Downes TD, ... ... London N, et al. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nature Communications. 11: 5047. PMID 33028810 DOI: 10.1038/s41467-020-18709-w  0.737
2020 Zaidman D, Prilusky J, London N. PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes. Journal of Chemical Information and Modeling. 60: 4894-4903. PMID 32976709 DOI: 10.1021/acs.jcim.0c00589  0.12
2020 Murakawa Y, Valter S, Barr H, London N, Kinoshita T. Structural basis for producing selective MAP2K7 inhibitors. Bioorganic & Medicinal Chemistry Letters. 30: 127546. PMID 32931911 DOI: 10.1016/j.bmcl.2020.127546  0.12
2020 Guo J, Douangamath A, Song W, Coker AR, Chan AWE, Wood SP, Cooper JB, Resnick E, London N, Delft FV. -screening for discovery of human norovirus 3C-like protease inhibitors. Journal of Structural Biology: X. 4: 100031. PMID 32743543 DOI: 10.1016/j.yjsbx.2020.100031  0.284
2020 Gabizon R, London N. Hitting KRAS When It's Down. Journal of Medicinal Chemistry. 63: 6677-6678. PMID 32568546 DOI: 10.1021/acs.jmedchem.0c00785  0.12
2020 Chodera J, Lee AA, London N, von Delft F. Crowdsourcing drug discovery for pandemics. Nature Chemistry. PMID 32555379 DOI: 10.1038/S41557-020-0496-2  0.099
2020 Gabizon R, Shraga A, Gehrtz P, Livnah E, Shorer Y, Gurwicz N, Avram L, Unger T, Aharoni H, Albeck S, Brandis A, Shulman Z, Katz BZ, Herishanu Y, London N. Correction to Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs. Journal of the American Chemical Society. 142: 11316. PMID 32520539 DOI: 10.1021/jacs.0c05753  0.12
2020 Pinch BJ, Doctor ZM, Nabet B, Browne CM, Seo HS, Mohardt ML, Kozono S, Lian X, Manz TD, Chun Y, Kibe S, Zaidman D, Daitchman D, Yeoh ZC, Vangos NE, ... ... London N, et al. Identification of a potent and selective covalent Pin1 inhibitor. Nature Chemical Biology. PMID 32483379 DOI: 10.1038/S41589-020-0550-9  0.239
2020 Leman JK, Weitzner BD, Lewis SM, Adolf-Bryfogle J, Alam N, Alford RF, Aprahamian M, Baker D, Barlow KA, Barth P, Basanta B, Bender BJ, Blacklock K, Bonet J, Boyken SE, ... ... London N, et al. Macromolecular modeling and design in Rosetta: recent methods and frameworks. Nature Methods. PMID 32483333 DOI: 10.1038/S41592-020-0848-2  0.58
2020 Gabizon R, London N. A Fast and Clean BTK Inhibitor. Journal of Medicinal Chemistry. 63: 5100-5101. PMID 32401033 DOI: 10.1021/acs.jmedchem.0c00597  0.12
2020 Gabizon R, Shraga A, Gehrtz P, Livnah E, Shorer Y, Gurwicz N, Avram L, Unger T, Aharoni H, Albeck S, Brandis A, Shulman Z, Katz BZ, Herishanu Y, London N. Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs. Journal of the American Chemical Society. 142: 11734-11742. PMID 32369353 DOI: 10.1021/jacs.9b13907  0.12
2019 Reznik N, Kozer N, Eisenberg-Lerner A, Barr H, Merbl Y, London N. Phenotypic screen identifies JAK2 as a major regulator of FAT10 expression. Acs Chemical Biology. PMID 31794190 DOI: 10.1021/Acschembio.9B00667  0.156
2019 Correy GJ, Zaidman D, Harmelin A, Carvalho S, Mabbitt PD, Calaora V, James PJ, Kotze AC, Jackson CJ, London N. Overcoming insecticide resistance through computational inhibitor design. Proceedings of the National Academy of Sciences of the United States of America. PMID 31575743 DOI: 10.1073/Pnas.1909130116  0.124
2019 Resnick E, Bradley A, Gan J, Douangamath A, Krojer T, Sethi R, Geurink PP, Aimon A, Amitai G, Bellini D, Bennett J, Fairhead M, Fedorov O, Gabizon R, Gan J, ... ... London N, et al. Rapid covalent-probe discovery by electrophile-fragment screening. Journal of the American Chemical Society. PMID 31060360 DOI: 10.1021/Jacs.9B02822  0.299
2018 Shraga A, Olshvang E, Davidzohn N, Khoshkenar P, Germain N, Shurrush K, Carvalho S, Avram L, Albeck S, Unger T, Lefker B, Subramanyam C, Hudkins RL, Mitchell A, Shulman Z, ... ... London N, et al. Covalent Docking Identifies a Potent and Selective MKK7 Inhibitor. Cell Chemical Biology. PMID 30449673 DOI: 10.1016/j.chembiol.2018.10.011  0.24
2018 Nnadi CI, Jenkins ML, Gentile DR, Bateman LA, Zaidman D, Balius TE, Nomura DK, Burke JE, Shokat KM, London N. Novel K-Ras G12C Switch-II covalent binders destabilize Ras and accelerate nucleotide exchange. Journal of Chemical Information and Modeling. PMID 29320178 DOI: 10.1021/Acs.Jcim.7B00399  0.719
2017 Ziarek JJ, Kleist AB, London N, Raveh B, Montpas N, Bonneterre J, St-Onge G, DiCosmo-Ponticello CJ, Koplinski CA, Roy I, Stephens B, Thelen S, Veldkamp CT, Coffman FD, Cohen MC, et al. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation. Science Signaling. 10. PMID 28325822 DOI: 10.1126/Scisignal.Aah5756  0.242
2015 Kincaid VA, London N, Wangkanont K, Wesener DA, Marcus SA, Héroux A, Nedyalkova L, Talaat AM, Forest KT, Shoichet BK, Kiessling LL. Virtual Screening for UDP-Galactopyranose Mutase Ligands Identifies a New Class of Antimycobacterial Agents. Acs Chemical Biology. 10: 2209-18. PMID 26214585 DOI: 10.1021/Acschembio.5B00370  0.516
2015 London N, Miller RM, Krishnan S, Uchida K, Irwin JJ, Eidam O, Gibold L, Cimerman?i? P, Bonnet R, Shoichet BK, Taunton J. Erratum: Covalent docking of large libraries for the discovery of chemical probes. Nature Chemical Biology. 11: 235. PMID 25689339 DOI: 10.1038/nchembio0315-235b  0.488
2015 London N, Farelli JD, Brown SD, Liu C, Huang H, Korczynska M, Al-Obaidi NF, Babbitt PC, Almo SC, Allen KN, Shoichet BK. Covalent docking predicts substrates for haloalkanoate dehalogenase superfamily phosphatases. Biochemistry. 54: 528-37. PMID 25513739 DOI: 10.1021/Bi501140K  0.481
2014 Gao M, London N, Cheng K, Tamura R, Jin J, Schueler-Furman O, Yin H. Rationally Designed Macrocyclic Peptides as Synergistic Agonists of LPS-Induced Inflammatory Response. Tetrahedron. 70: 7664-7668. PMID 25400297 DOI: 10.1016/J.Tet.2014.07.026  0.577
2014 London N, Miller RM, Krishnan S, Uchida K, Irwin JJ, Eidam O, Gibold L, Cimermančič P, Bonnet R, Shoichet BK, Taunton J. Covalent docking of large libraries for the discovery of chemical probes. Nature Chemical Biology. 10: 1066-72. PMID 25344815 DOI: 10.1038/Nchembio.1666  0.578
2014 Dong GQ, Calhoun S, Fan H, Kalyanaraman C, Branch MC, Mashiyama ST, London N, Jacobson MP, Babbitt PC, Shoichet BK, Armstrong RN, Sali A. Prediction of substrates for glutathione transferases by covalent docking. Journal of Chemical Information and Modeling. 54: 1687-99. PMID 24802635 DOI: 10.1021/Ci5001554  0.515
2013 London N, Raveh B, Schueler-Furman O. Druggable protein-protein interactions--from hot spots to hot segments. Current Opinion in Chemical Biology. 17: 952-9. PMID 24183815 DOI: 10.1016/J.Cbpa.2013.10.011  0.631
2013 London N, Raveh B, Schueler-Furman O. Peptide docking and structure-based characterization of peptide binding: from knowledge to know-how. Current Opinion in Structural Biology. 23: 894-902. PMID 24138780 DOI: 10.1016/J.Sbi.2013.07.006  0.666
2013 London N, Ambroggio X. An accurate binding interaction model in de novo computational protein design of interactions: if you build it, they will bind. Journal of Structural Biology. 185: 136-46. PMID 23558036 DOI: 10.1016/j.jsb.2013.03.012  0.307
2012 Wexselblatt E, Oppenheimer-Shaanan Y, Kaspy I, London N, Schueler-Furman O, Yavin E, Glaser G, Katzhendler J, Ben-Yehuda S. Relacin, a novel antibacterial agent targeting the Stringent Response. Plos Pathogens. 8: e1002925. PMID 23028324 DOI: 10.1371/Journal.Ppat.1002925  0.542
2012 London N, Gullá S, Keating AE, Schueler-Furman O. In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2. Biochemistry. 51: 5841-50. PMID 22702834 DOI: 10.1021/Bi3003567  0.645
2012 London N, Raveh B, Schueler-Furman O. Modeling peptide-protein interactions. Methods in Molecular Biology (Clifton, N.J.). 857: 375-98. PMID 22323231 DOI: 10.1007/978-1-61779-588-6_17  0.651
2011 Fleishman SJ, Whitehead TA, Strauch EM, Corn JE, Qin S, Zhou HX, Mitchell JC, Demerdash ON, Takeda-Shitaka M, Terashi G, Moal IH, Li X, Bates PA, Zacharias M, Park H, ... ... London N, et al. Community-wide assessment of protein-interface modeling suggests improvements to design methodology. Journal of Molecular Biology. 414: 289-302. PMID 22001016 DOI: 10.1016/J.Jmb.2011.09.031  0.634
2011 London N, Lamphear CL, Hougland JL, Fierke CA, Schueler-Furman O. Identification of a novel class of farnesylation targets by structure-based modeling of binding specificity. Plos Computational Biology. 7: e1002170. PMID 21998565 DOI: 10.1371/Journal.Pcbi.1002170  0.657
2011 Al-Quadan T, Price CT, London N, Schueler-Furman O, AbuKwaik Y. Anchoring of bacterial effectors to host membranes through host-mediated lipidation by prenylation: a common paradigm. Trends in Microbiology. 19: 573-9. PMID 21983544 DOI: 10.1016/J.Tim.2011.08.003  0.54
2011 London N, Raveh B, Cohen E, Fathi G, Schueler-Furman O. Rosetta FlexPepDock web server--high resolution modeling of peptide-protein interactions. Nucleic Acids Research. 39: W249-53. PMID 21622962 DOI: 10.1093/Nar/Gkr431  0.637
2011 Raveh B, London N, Zimmerman L, Schueler-Furman O. Rosetta FlexPepDock ab-initio: simultaneous folding, docking and refinement of peptides onto their receptors. Plos One. 6: e18934. PMID 21572516 DOI: 10.1371/Journal.Pone.0018934  0.629
2011 Belitsky M, Avshalom H, Erental A, Yelin I, Kumar S, London N, Sperber M, Schueler-Furman O, Engelberg-Kulka H. The Escherichia coli extracellular death factor EDF induces the endoribonucleolytic activities of the toxins MazF and ChpBK. Molecular Cell. 41: 625-35. PMID 21419338 DOI: 10.1016/J.Molcel.2011.02.023  0.558
2011 Crawley SW, Gharaei MS, Ye Q, Yang Y, Raveh B, London N, Schueler-Furman O, Jia Z, Côté GP. Autophosphorylation activates Dictyostelium myosin II heavy chain kinase A by providing a ligand for an allosteric binding site in the alpha-kinase domain. The Journal of Biological Chemistry. 286: 2607-16. PMID 21071445 DOI: 10.1074/Jbc.M110.177014  0.572
2010 Buch I, Fishelovitch D, London N, Raveh B, Wolfson HJ, Nussinov R. Allosteric regulation of glycogen synthase kinase 3β: a theoretical study. Biochemistry. 49: 10890-901. PMID 21105670 DOI: 10.1021/Bi100822Q  0.219
2010 London N, Raveh B, Movshovitz-Attias D, Schueler-Furman O. Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions? Proteins. 78: 3140-9. PMID 20607702 DOI: 10.1002/Prot.22785  0.654
2010 Raveh B, London N, Schueler-Furman O. Sub-angstrom modeling of complexes between flexible peptides and globular proteins. Proteins. 78: 2029-40. PMID 20455260 DOI: 10.1002/Prot.22716  0.649
2010 Movshovitz-Attias D, London N, Schueler-Furman O. On the use of structural templates for high-resolution docking. Proteins. 78: 1939-49. PMID 20408170 DOI: 10.1002/Prot.22710  0.614
2010 Kanarek N, London N, Schueler-Furman O, Ben-Neriah Y. Ubiquitination and degradation of the inhibitors of NF-kappaB. Cold Spring Harbor Perspectives in Biology. 2: a000166. PMID 20182612 DOI: 10.1101/Cshperspect.A000166  0.517
2010 London N, Movshovitz-Attias D, Schueler-Furman O. The structural basis of peptide-protein binding strategies. Structure (London, England : 1993). 18: 188-99. PMID 20159464 DOI: 10.1016/J.Str.2009.11.012  0.652
2009 Dassa B, London N, Stoddard BL, Schueler-Furman O, Pietrokovski S. Fractured genes: a novel genomic arrangement involving new split inteins and a new homing endonuclease family. Nucleic Acids Research. 37: 2560-73. PMID 19264795 DOI: 10.1093/Nar/Gkp095  0.531
2008 London N, Schueler-Furman O. FunHunt: model selection based on energy landscape characteristics. Biochemical Society Transactions. 36: 1418-21. PMID 19021567 DOI: 10.1042/Bst0361418  0.591
2008 London N, Schueler-Furman O. Funnel hunting in a rough terrain: learning and discriminating native energy funnels. Structure (London, England : 1993). 16: 269-79. PMID 18275818 DOI: 10.1016/J.Str.2007.11.013  0.576
2007 London N, Schueler-Furman O. Assessing the energy landscape of CAPRI targets by FunHunt. Proteins. 69: 809-15. PMID 17803233 DOI: 10.1002/Prot.21736  0.582
2007 Wang C, Schueler-Furman O, Andre I, London N, Fleishman SJ, Bradley P, Qian B, Baker D. RosettaDock in CAPRI rounds 6-12. Proteins. 69: 758-63. PMID 17671979 DOI: 10.1002/Prot.21684  0.666
Show low-probability matches.